These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 3814476)

  • 41. Tumor characteristics and recurrence patterns in triple negative breast cancer: a comparison between younger (<65) and elderly (≥65) patients.
    Königsberg R; Pfeiler G; Klement T; Hammerschmid N; Brunner A; Zeillinger R; Singer C; Dittrich C
    Eur J Cancer; 2012 Nov; 48(16):2962-8. PubMed ID: 22647688
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral pamidronate in the prevention and treatment of skeletal metastases in patients with breast cancer.
    van Holten-Verzantvoort AT; Papapoulos SE
    Medicina (B Aires); 1997; 57 Suppl 1():109-13. PubMed ID: 9567363
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal surveillance for postoperative metastasis in breast cancer patients.
    Makita M; Sakai T; Ogiya A; Kitagawa D; Morizono H; Miyagi Y; Iijima K; Iwase T
    Breast Cancer; 2016 Mar; 23(2):286-94. PubMed ID: 25294313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Histological grade and steroid receptor content of primary breast cancer--impact on prognosis and possible modes of action.
    Kamby C; Andersen J; Ejlertsen B; Birkler NE; Rytter L; Zedeler K; Thorpe SM; Nørgaard T; Rose C
    Br J Cancer; 1988 Oct; 58(4):480-6. PubMed ID: 3207602
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of triple-negative phenotype on prognosis of patients with breast cancer brain metastases.
    Xu Z; Schlesinger D; Toulmin S; Rich T; Sheehan J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):612-8. PubMed ID: 22436795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Norethisterone acetate in the treatment of advanced breast cancer.
    Earl HM; Rubens RD; Knight RK; Hayward JL
    Clin Oncol; 1984 Jun; 10(2):103-9. PubMed ID: 6734001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Symptomatic bone marrow involvement in breast cancer--clinical presentation, treatment, and prognosis: a single institution review of 22 cases.
    Kopp HG; Krauss K; Fehm T; Staebler A; Zahm J; Vogel W; Kanz L; Mayer F
    Anticancer Res; 2011 Nov; 31(11):4025-30. PubMed ID: 22110237
    [TBL] [Abstract][Full Text] [Related]  

  • 48. First-line endocrine therapy alone could be a reasonable treatment option for hormone-positive, HER2-positive metastatic breast cancer.
    Peron J; Tredan O; Ray-Coquard I; Bachelot T; Labidi Galy SI; Favier B; Treilleux I; Guastalla JP
    Bull Cancer; 2012 Feb; 99(2):E18-25. PubMed ID: 22257781
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The influence of breast cancer subtype on bone metastases development and survival in women with metastatic breast cancer.
    Piggott RP; Waters PS; Kerin MJ
    Ir J Med Sci; 2017 Feb; 186(1):97-102. PubMed ID: 27734241
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies.
    Amir E; Ooi WS; Simmons C; Kahn H; Christakis M; Popovic S; Kalina M; Chesney A; Singh G; Clemons M
    Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):763-8. PubMed ID: 18824337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study.
    Muss HB; Case LD; Atkins JN; Bearden JD; Cooper MR; Cruz JM; Jackson DV; O'Rourke MA; Pavy MD; Powell BL
    J Clin Oncol; 1994 Aug; 12(8):1630-8. PubMed ID: 8040675
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells.
    Ogba N; Manning NG; Bliesner BS; Ambler SK; Haughian JM; Pinto MP; Jedlicka P; Joensuu K; Heikkilä P; Horwitz KB
    Breast Cancer Res; 2014 Dec; 16(6):489. PubMed ID: 25475897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes.
    Cancello G; Maisonneuve P; Rotmensz N; Viale G; Mastropasqua MG; Pruneri G; Montagna E; Dellapasqua S; Iorfida M; Cardillo A; Veronesi P; Luini A; Intra M; Gentilini O; Scarano E; Goldhirsch A; Colleoni M
    Breast Cancer Res Treat; 2011 Jun; 127(3):713-20. PubMed ID: 21452022
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence and patterns of distant metastases for patients with early-stage breast cancer after breast conservation treatment.
    Berman AT; Thukral AD; Hwang WT; Solin LJ; Vapiwala N
    Clin Breast Cancer; 2013 Apr; 13(2):88-94. PubMed ID: 23218473
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of breast cancer based on its specific biological behavior].
    Tominaga T
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2718-25. PubMed ID: 3753020
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A case of stage IV breast cancer with bone metastases that responded well for long-term to hormonal therapy].
    Oda G; Nakagawa T; Sato T; Kuwayama T; Yamamoto K; Kawachi H; Kubota K; Sugihara K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2753-5. PubMed ID: 21224702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic factors for survival in breast cancer patients who developed distant metastasis subsequent to definitive surgery.
    Kuru B; Camlibel M; Dinc S; Gulcelik MA; Gonullu D; Alagol H
    Singapore Med J; 2008 Nov; 49(11):904-11. PubMed ID: 19037557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progesterone receptor status of breast cancer metastases.
    Branković-Magić M; Janković R; Nesković-Konstantinović Z; Nikolić-Vukosavljević D
    J Cancer Res Clin Oncol; 2002 Jan; 128(1):55-60. PubMed ID: 11862473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence and prognostic factors of Japanese breast cancer patients with bone metastasis.
    Oka H; Kondoh T; Seichi A; Hozumi T; Nakamura K
    J Orthop Sci; 2006 Jan; 11(1):13-9. PubMed ID: 16437343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
    Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG
    Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.